ARTICLE | Clinical News
MSP-2017: Phase I started
November 4, 2013 8:00 AM UTC
Milestone began a double-blind, placebo-controlled, crossover, Australian Phase I trial to evaluate single ascending-doses of 2 intranasal formulations of MSP-2017 in healthy adult volunteers. ...